Payer & Health Plan Administration · Healthcare & Life Sciences
Should you build or buy Health Insurance Prior Authorization Automation?
Health Insurance Prior Authorization Automation software streamlines the submission, clinical criteria review, and determination workflow for prior authorization requests from providers. It automates approval routing for straightforward cases, applies clinical criteria (InterQual, MCG, or plan-specific guidelines) to support medical necessity determinations, and connects to provider EHR systems via FHIR APIs to meet CMS interoperability mandates taking effect in 2026.
The build-vs-buy decision for Health Insurance Prior Authorization Automation turns on how much the CMS FHIR interoperability mandates and licensed clinical criteria requirements create a compliance-first build constraint that independent teams can't meet on timeline, and how much the member experience and provider relationship benefits of automation create strategic separation; the calculus has been stable given regulatory complexity.
Build it, buy it, or bridge?
When building makes sense
The build case for prior authorization automation is constrained by two factors that don't respond to engineering capability. Clinical criteria, InterQual and MCG guidelines that define what gets approved, are third-party licensed datasets not freely available for internal builds. CMS interoperability mandates require FHIR-based API integration by 2026, and that standards work requires dedicated compliance infrastructure that vendors built specifically for this purpose. No independent team has shipped a production PA platform covering the FHIR requirements plus criteria application at the scale a health plan needs. Where internal investment does make sense is in the plan-specific routing logic and approval automation above the criteria layer: building auto-approval rules for your specific formulary exceptions, procedure codes your plan treats differently from MCG defaults, or provider portal enhancements that improve the authorization experience for your network. That customization layer runs on top of vendor FHIR infrastructure rather than replacing it.
When buying makes sense
Buying is the correct call for most health plans facing the 2026 CMS real-time PA mandate because the compliance infrastructure required specific FHIR standards work that vendors had already built before the deadline became urgent. Clinical criteria licensing is a fixed cost regardless of whether a plan builds or buys, but vendors package that licensing with the workflow platform in ways that reduce integration overhead. Platforms like Cohere Health, Myndshft, and Availity AuthAI have AI auto-approval in production and established FHIR connectivity, which means a plan can meet the regulatory deadline without staffing a clinical APIs team. The member experience and provider relationship benefits of faster and more transparent authorization decisions are real strategic arguments, but they're accessible through vendor auto-approval rates without owning the underlying infrastructure.
The desk read
CMS interoperability mandates for real-time prior authorization, requiring FHIR-based API integration by 2026, pushed health plans toward vendor solutions because the compliance infrastructure required specific standards work that vendors had already built. Clinical criteria licensing, InterQual and MCG guidelines that define what gets approved, are third-party licensed datasets that aren't freely available for self-builds. Platforms like Cohere Health and Waystar provide both the FHIR compliance layer and the criteria application engine. For most health plans, that bundle is the path of least resistance to meeting the regulatory deadline.
Buying earns its keep when your primary constraint is CMS compliance timing and when your clinical criteria follow licensed standard guidelines rather than proprietary plan-specific rules. The build case is weak here partly because the compliance overhead is fixed regardless of approach, and partly because no independent team has shipped a production PA platform that covers the full FHIR requirements plus clinical criteria application. The AI opportunity is in augmenting vendor platforms, auto-routing straightforward approvals and flagging edge cases, not in replacing the compliance infrastructure.
Frequently asked
What is Health Insurance Prior Authorization Automation software?
Health Insurance Prior Authorization Automation software streamlines the submission, clinical criteria review, and determination workflow for prior authorization requests from providers. It automates approval routing for straightforward cases, applies clinical criteria (InterQual, MCG, or plan-specific guidelines) to support medical necessity determinations, and connects to provider EHR systems via FHIR APIs to meet CMS interoperability mandates taking effect in 2026.
When does building Health Insurance Prior Authorization Automation make sense?
Building the full PA platform isn't practical given CMS FHIR mandate timelines and clinical criteria licensing requirements. Internal investment makes sense for plan-specific routing logic and custom approval automation above a vendor-managed FHIR and criteria layer.
When does buying Health Insurance Prior Authorization Automation make sense?
Buying makes sense for health plans facing the 2026 CMS real-time PA mandate, where vendor FHIR infrastructure and licensed clinical criteria application solve the compliance problem on a timeline that self-builds can't match. No independent team has shipped a production equivalent.
What are the main Health Insurance Prior Authorization Automation vendors?
Representative vendors include Cohere Health, Myndshft, Availity AuthAI, Rhyme. B4 Pro scores the full set.
What does the CMS real-time prior authorization mandate require?
CMS regulations effective in 2026 require Medicare Advantage and Medicaid managed care plans to implement FHIR-based APIs that give providers real-time responses to prior authorization requests for certain services. Plans that don't meet the standard face compliance exposure and provider relations consequences.